DaVita Inc.
DVA
Hisse Senetlerindeki Sıralama
#1799
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Hisse Fiyatı
$186.81
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$11.92B
Değişim (1 gün)
-1.10%
Değişim (1 yıl)
48.40%
Ülke
US
Ticaret DaVita Inc. (DVA)
Kategori
Healthcare
DaVita Inc. (DVA) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 15.06%
DaVita Inc. şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 15.06%'dir. 2024 yılı sonunda şirketin faaliyet marjı 16.31% idi.
DaVita Inc. için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 15.06% | 4.95% |
| 2025 | 14.35% | -12.02% |
| 2024 | 16.31% | 23.56% |
| 2023 | 13.20% | 14.48% |
| 2022 | 11.53% | -25.47% |
| 2021 | 15.47% | 5.45% |
| 2020 | 14.67% | 1.66% |
| 2019 | 14.43% | 7.85% |
| 2018 | 13.38% | -19.74% |
| 2017 | 16.67% | 21.06% |
| 2016 | 13.77% | 66.91% |
| 2015 | 8.25% | -41.86% |
| 2014 | 14.19% | 7.66% |
| 2013 | 13.18% | -16.79% |
| 2012 | 15.84% | -6.82% |
| 2011 | 17.00% | 10.32% |
| 2010 | 15.41% | 0.13% |
| 2009 | 15.39% | 0.26% |
| 2008 | 15.35% | -6.29% |
| 2007 | 16.38% | 8.12% |
| 2006 | 15.15% | -3.19% |
| 2005 | 15.65% | -5.61% |
| 2004 | 16.58% | -5.74% |
| 2003 | 17.59% | -15.02% |
| 2002 | 20.70% | 9.93% |
| 2001 | 18.83% | 56.14% |
| 2000 | 12.06% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 15.48% | -98.97% |
US
|
|
| 0.00% | - |
DE
|
|
| 16.80% | -98.88% |
US
|
|
| 18.67% | -98.76% |
SA
|
|
| 0.00% | - |
MY
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.